Low-level laser irradiation-based anti-telomerase therapy: Low-level laser irradiation suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) and the cellular immortality gene telomerase and inhibits cancer progression via down-regulation of it target gene, 31/May/2017, 11.08 pm

Mineral-rich water-based cardiac regeneration therapy: Mineral-rich water therapy suppresses tumor suppressor INK4a/p16 expression, inhibits dilated cardiomyopathy and heart failure and extends life span via up regulation of its target gene, 31/May/2017, 11.05 pm
May 31, 2017
Natural product-derived therapy for Stroke: Isoliquiritigenin (ILQ), isolated from Liquorice, attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT. 2/June/2017, 11.34 pm
June 2, 2017
Show all

Introduction: What they say:  

The 1989 Nobel prize winner in Chemistry, Prof. Thomas R. Cech from the BioFrontiers Institute, USA has published a research paper in the 13 December 2012 issue of the Nature journal (492(7428):285-9; and I.F: >42) stating that “The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity.”  This study provides mechanistic insights into how TPP1 regulates telomerase function.


What we say

In connection with this finding,  Dr Boominathan, Founder Director-cum-chief scientist of GBMD, reports, for the first time, thatLow-level laser irradiation-based anti-telomerase therapy: Low-level laser irradiation suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) and the cellular immortality gene telomerase and inhibits cancer progression via down-regulation of it target gene

price-50


Significance of the study:

Given that: (1) over 90% human tumors overexpress immortality gene telomerase; and (2) cancer causes the highest economic loss compared to all the known causes of death worldwide, there is an urgent need to find: (i) a way to inhibit telomerase activity in human tumors; (ii) a way to increase the efficacy of anticancer therapy;  (iii) a cheaper alternative to the existing expensive drugs; (iv) a side-effect-free natural product-based drug; (v) a way to effectively treat cancers that are resistant to anticancer drugs;  (vi) a way to prevent tumor recurrence; and (vii) a way to effectively treat and eradicate metastatic progression of cancer.


From Research Findings to Therapeutic opportunity:

This study suggests that Low-level laser irradiation, by increasing the expression of its downstream target genes, it may suppress the expression of Tripeptidyl Peptidase 1 (TPP1) and Telomerase (Fig 1). Remarkably, over 90% of the human tumors overexpress the cellular immortality gene telomerase, suggesting that inhibition of its activity may increase the efficacy of anticancer therapy. [easy_payment currency=”USD”]

Thus,  Low-level laser irradiation therapy may be advised for cancer patients to (i) inhibit the expression of telomerase in tumors; and (ii) enhance the efficacy of Cancer therapy. Together,  oncologists may consider adopting  Low-level laser irradiation therapy in the treatment of Cancer, especially in tumors that specifically overexpress the cellular immortality gene  telomerase. 

Figure 1 Mechanistic insights into how Low-level laser irradiation functions as an anti-telomerase/cancer suppressor agent.  Low-level laser irradiation, by increasing the expression of Tripeptidyl Peptidase 1 (TPP1) and the cellular immortality gene telomerase, inhibits cancer cell proliferation.


Details of the Research findings:

Idea Proposed/Formulated (with experimental evidence) by:

Dr L Boominathan Ph.D.

Amount: $50#

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic information: How  Low-level laser irradiation  suppresses the expression of Tripeptidyl Peptidase 1 (TPP1)/telomerase?
For purchase and payment details, you may reach us at admin@genomediscovery.org

# Research cooperation


References:

CitationBoominathan, L., Low-level laser irradiation-based anti-telomerase therapy: Low-level laser irradiation suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) and the cellular immortality gene telomerase and inhibits cancer progression via down-regulation of it target gene, 31/May/2017, 11.08 pm,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at admin@genomediscovery.org

Web: http://genomediscovery.org or http://newbioideas.com/

Comments are closed.